{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:38:10Z","timestamp":1791225490378,"version":"4.1.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T00:00:00Z","timestamp":1373500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003495","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T20:52:31Z","timestamp":1373575951000},"page":"e1003495","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":78,"title":["Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines"],"prefix":"10.1371","volume":"9","author":[{"given":"Pan","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthandan","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Kirtley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"van Lier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsey A.","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K.","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venigalla B.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2013etiologic agent of plague","volume":"10","author":"RD Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1086\/428617","article-title":"Risk of person-to-person transmission of pneumonic plague","volume":"40","author":"JL Kool","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00253-011-3380-6","article-title":"Progress on plague vaccine development","volume":"91","author":"JA Rosenzweig","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"TV Inglesby","year":"2000","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/10408410500496896","article-title":"The anti-plague system and the Soviet biological warfare program","volume":"32","author":"RA Zilinskas","year":"2006","journal-title":"Crit Rev Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"ST Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/IAI.01067-12","article-title":"Deletion of Braun lipoprotein encoding gene and altering the function of lipopolysaccharide attenuate plague bacterium","volume":"81","author":"J Sha","year":"2013","journal-title":"Infect Immun"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"VA Feodorova","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/jmm.0.037960-0","article-title":"The natural history and incidence of Yersinia pestis and prospects for vaccination","volume":"61","author":"ED Williamson","year":"2012","journal-title":"J Med Microbiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(03)00351-9","article-title":"Structure and biogenesis of the capsular F1 antigen from Yersinia pestis: preserved folding energy drives fiber formation","volume":"113","author":"AV Zavialov","year":"2003","journal-title":"Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pmed.0050003","article-title":"Plague: past, present, and future","volume":"5","author":"NC Stenseth","year":"2008","journal-title":"PLoS Med"},{"key":"ref12","first-page":"301","article-title":"The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague","volume":"12","author":"U Derewenda","year":"2004","journal-title":"Structure"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1128\/IAI.71.7.3673-3681.2003","article-title":"Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen)","volume":"71","author":"RR Brubaker","year":"2003","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"ED Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"GW Anderson Jr","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"DG Heath","year":"1998","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1016\/j.vaccine.2009.07.068","article-title":"Plague","volume":"27 Suppl 4","author":"ED Williamson","year":"2009","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"ED Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"SB Mizel","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pep.2006.12.018","article-title":"Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague","volume":"53","author":"JL Goodin","year":"2007","journal-title":"Protein Expr Purif"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pep.2010.10.011","article-title":"Purification and characterization of a recombinant Yersinia pestis V-F1 \u201cReversed\u201d fusion protein for use as a new subunit vaccine against plague","volume":"76","author":"JL Goodin","year":"2011","journal-title":"Protein Expr Purif"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"BS Powell","year":"2005","journal-title":"Biotechnol Prog"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"MA Parent","year":"2005","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/clinids\/21.Supplement_2.S178","article-title":"Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis","volume":"21 Suppl 2","author":"AM Friedlander","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref25","first-page":"325","article-title":"Construction of defined F1 negative mutants of virulent Yersinia pestis","volume":"13","author":"PL Worsham","year":"1995","journal-title":"Contrib Microbiol Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/IAI.65.2.446-451.1997","article-title":"Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen","volume":"65","author":"A Roggenkamp","year":"1997","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/CVI.00597-12","article-title":"Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new generation recombinant plague vaccine","volume":"20","author":"TE Erova","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1128\/IAI.01860-05","article-title":"Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV","volume":"74","author":"KL DeBord","year":"2006","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jmb.2006.08.049","article-title":"Bacteriophage T4 capsid: a unique platform for efficient surface assembly of macromolecular complexes","volume":"363","author":"Q Li","year":"2006","journal-title":"J Mol Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jmb.2007.05.008","article-title":"Assembly of the small outer capsid protein, Soc, on bacteriophage T4: a novel system for high density display of multiple large anthrax toxins and foreign proteins on phage capsid","volume":"370","author":"Q Li","year":"2007","journal-title":"J Mol Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2006.10.010","article-title":"Multicomponent anthrax toxin display and delivery using bacteriophage T4","volume":"25","author":"SB Shivachandra","year":"2007","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1128\/JVI.00235-06","article-title":"Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines","volume":"80","author":"T Sathaliyawala","year":"2006","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-0-12-394621-8.00018-2","article-title":"Structure, assembly, and DNA packaging of the bacteriophage T4 head","volume":"82","author":"LW Black","year":"2012","journal-title":"Adv Virus Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jmb.2009.10.007","article-title":"Structure of the small outer capsid protein, Soc: a clamp for stabilizing capsids of T4-like phages","volume":"395","author":"L Qin","year":"2009","journal-title":"J Mol Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1128\/JVI.00847-11","article-title":"Structure of the three N-terminal immunoglobulin domains of the highly immunogenic outer capsid protein from a T4-like bacteriophage","volume":"85","author":"A Fokine","year":"2011","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2958.2010.07219.x","article-title":"Functional analysis of the highly antigenic outer capsid protein, Hoc, a virus decoration protein from T4-like bacteriophages","volume":"77","author":"T Sathaliyawala","year":"2010","journal-title":"Mol Microbiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0022-2836(77)80088-0","article-title":"The two dispensable structural proteins (soc and hoc) of the T4 phage capsid; their purification and properties, isolation and characterization of the defective mutants, and their binding with the defective heads in vitro","volume":"109","author":"T Ishii","year":"1977","journal-title":"J Mol Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/IAI.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"GP Andrews","year":"1996","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-695X.1998.tb01168.x","article-title":"Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity","volume":"21","author":"J Miller","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"26129","DOI":"10.1074\/jbc.M605482200","article-title":"Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes","volume":"281","author":"JA Musson","year":"2006","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1128\/IAI.73.8.5152-5159.2005","article-title":"LcrV plague vaccine with altered immunomodulatory properties","volume":"73","author":"KA Overheim","year":"2005","journal-title":"Infect Immun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2180-5-38","article-title":"Immunization of mice with YscF provides protection from Yersinia pestis infections","volume":"5","author":"JS Matson","year":"2005","journal-title":"BMC Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/JB.01396-06","article-title":"Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells","volume":"189","author":"AJ Davis","year":"2007","journal-title":"J Bacteriol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4161\/hv.9866","article-title":"Plague vaccines and the molecular basis of immunity against Yersinia pestis","volume":"5","author":"LE Quenee","year":"2009","journal-title":"Hum Vaccin"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"ST Smiley","year":"2008","journal-title":"Immunol Rev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/eji.200737799","article-title":"Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205\/CD205-positive mouse dendritic cells","volume":"38","author":"Y Do","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.micinf.2008.11.009","article-title":"Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92","volume":"11","author":"SL Agar","year":"2009","journal-title":"Microbes Infect"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1128\/IAI.00437-06","article-title":"Immunogenicity of a Yersinia pestis vaccine antigen monomerized by circular permutation","volume":"74","author":"DA Chalton","year":"2006","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.20020908","article-title":"Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression","volume":"196","author":"A Sing","year":"2002","journal-title":"J Exp Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.imlet.2005.02.009","article-title":"Yersinia rLcrV and rYopB inhibits the activation of murine peritoneal macrophages in vitro","volume":"99","author":"A Sodhi","year":"2005","journal-title":"Immunol Lett"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vaccine.2010.08.099","article-title":"TNFalpha and IFNgamma contribute to F1\/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague","volume":"29","author":"JS Lin","year":"2010","journal-title":"Vaccine"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.20021311","article-title":"A plague on host defense","volume":"196","author":"E Kopp","year":"2002","journal-title":"J Exp Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2010.12.062","article-title":"Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge","volume":"29","author":"S Wang","year":"2011","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"AV Philipovskiy","year":"2007","journal-title":"Infect Immun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.vaccine.2009.02.016","article-title":"CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague","volume":"27","author":"K Amemiya","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1128\/IAI.00316-13","article-title":"Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection","volume":"81","author":"AJ Hickey","year":"2013","journal-title":"Infect Immun"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/CVI.05376-11","article-title":"Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores","volume":"19","author":"KK Peachman","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.vaccine.2010.11.049","article-title":"Highly effective generic adjuvant systems for orphan or poverty-related vaccines","volume":"29","author":"M Rao","year":"2011","journal-title":"Vaccine"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy","volume":"49","author":"A Bruttin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1073\/pnas.1300867110","article-title":"In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine","volume":"110","author":"P Tao","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(89)90359-4","article-title":"Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension","volume":"77","author":"RM Horton","year":"1989","journal-title":"Gene"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"W474","DOI":"10.1093\/nar\/gkq407","article-title":"MetaMHC: a meta approach to predict peptides binding to MHC molecules","volume":"38","author":"X Hu","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"LA Brito","year":"2011","journal-title":"J Pharm Sci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1099\/mic.0.2008\/017335-0","article-title":"Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92","volume":"154","author":"SL Agar","year":"2008","journal-title":"Microbiology"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T12:36:19Z","timestamp":1596112579000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003495"}},"subtitle":[],"editor":[{"given":"Tomoko","family":"Kubori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,11]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003495","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,11]]}}}